U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Depigmented fundus

MedGen UID:
870372
Concept ID:
C4024816
Finding
HPO: HP:0007680

Term Hierarchy

Conditions with this feature

Ocular albinism, type I
MedGen UID:
90991
Concept ID:
C0342684
Disease or Syndrome
Ocular albinism type I (OA1) is the most common form of ocular albinism. Clinical presentation of OA1 in Caucasians is characterized by nystagmus, impaired visual acuity, iris hypopigmentation with translucency, albinotic fundus, macular hypoplasia, and normally pigmented skin and hair. Carrier females usually have punctate iris translucency and a mottled pattern of fundus pigmentation. In contrast to Caucasian patients, black or Japanese patients with OA1 often have brown irides with little or no translucency and varying degrees of fundus hypopigmentation, the so-called 'nonalbinotic fundus' (summary by Xiao and Zhang, 2009).
Ocular albinism with late-onset sensorineural deafness
MedGen UID:
337149
Concept ID:
C1845069
Congenital Abnormality
Ocular albinism is a genetic condition that primarily affects the eyes. This condition reduces the coloring (pigmentation) of the iris, which is the colored part of the eye, and the retina, which is the light-sensitive tissue at the back of the eye. Pigmentation in the eye is essential for normal vision.\n\nOcular albinism is characterized by severely impaired sharpness of vision (visual acuity) and problems with combining vision from both eyes to perceive depth (stereoscopic vision). Although the vision loss is permanent, it does not worsen over time. Other eye abnormalities associated with this condition include rapid, involuntary eye movements (nystagmus); eyes that do not look in the same direction (strabismus); and increased sensitivity to light (photophobia). Many affected individuals also have abnormalities involving the optic nerves, which carry visual information from the eye to the brain.\n\nThe most common form of ocular albinism is known as the Nettleship-Falls type or type 1. Other forms of ocular albinism are much rarer and may be associated with additional signs and symptoms, such as hearing loss.\n\nUnlike some other forms of albinism, ocular albinism does not significantly affect the color of the skin and hair. People with this condition may have a somewhat lighter complexion than other members of their family, but these differences are usually minor.

Recent clinical studies

Etiology

Lages V, Skvortsova N, Jeannin B, Gasc A, Herbort CP
Int Ophthalmol 2019 Sep;39(9):2111-2120. Epub 2018 Nov 24 doi: 10.1007/s10792-018-1050-8. PMID: 30474776
Herbort CP, Probst K, Cimino L, Tran VT
Klin Monbl Augenheilkd 2004 May;221(5):351-6. doi: 10.1055/s-2004-812827. PMID: 15162278
Sonoda S, Nakao K, Ohba N
Jpn J Ophthalmol 1999 Mar-Apr;43(2):113-9. doi: 10.1016/s0021-5155(98)00066-5. PMID: 10340793
Bergink GJ, Ooyman FM, Maas S, Rademakers AJ
Acta Ophthalmol Scand 1996 Feb;74(1):81-3. doi: 10.1111/j.1600-0420.1996.tb00689.x. PMID: 8689490

Diagnosis

Alsakran WA, Almadhi NH, Alshamrani AA, Alzahrani YA
Am J Case Rep 2020 Sep 8;21:e925926. doi: 10.12659/AJCR.925926. PMID: 32895362Free PMC Article
Lages V, Skvortsova N, Jeannin B, Gasc A, Herbort CP
Int Ophthalmol 2019 Sep;39(9):2111-2120. Epub 2018 Nov 24 doi: 10.1007/s10792-018-1050-8. PMID: 30474776
Herbort CP, Probst K, Cimino L, Tran VT
Klin Monbl Augenheilkd 2004 May;221(5):351-6. doi: 10.1055/s-2004-812827. PMID: 15162278
Bergink GJ, Ooyman FM, Maas S, Rademakers AJ
Acta Ophthalmol Scand 1996 Feb;74(1):81-3. doi: 10.1111/j.1600-0420.1996.tb00689.x. PMID: 8689490

Therapy

Lages V, Skvortsova N, Jeannin B, Gasc A, Herbort CP
Int Ophthalmol 2019 Sep;39(9):2111-2120. Epub 2018 Nov 24 doi: 10.1007/s10792-018-1050-8. PMID: 30474776
Herbort CP, Probst K, Cimino L, Tran VT
Klin Monbl Augenheilkd 2004 May;221(5):351-6. doi: 10.1055/s-2004-812827. PMID: 15162278
Sonoda S, Nakao K, Ohba N
Jpn J Ophthalmol 1999 Mar-Apr;43(2):113-9. doi: 10.1016/s0021-5155(98)00066-5. PMID: 10340793
Bergink GJ, Ooyman FM, Maas S, Rademakers AJ
Acta Ophthalmol Scand 1996 Feb;74(1):81-3. doi: 10.1111/j.1600-0420.1996.tb00689.x. PMID: 8689490

Prognosis

Lages V, Skvortsova N, Jeannin B, Gasc A, Herbort CP
Int Ophthalmol 2019 Sep;39(9):2111-2120. Epub 2018 Nov 24 doi: 10.1007/s10792-018-1050-8. PMID: 30474776
Herbort CP, Probst K, Cimino L, Tran VT
Klin Monbl Augenheilkd 2004 May;221(5):351-6. doi: 10.1055/s-2004-812827. PMID: 15162278
Sonoda S, Nakao K, Ohba N
Jpn J Ophthalmol 1999 Mar-Apr;43(2):113-9. doi: 10.1016/s0021-5155(98)00066-5. PMID: 10340793
Bergink GJ, Ooyman FM, Maas S, Rademakers AJ
Acta Ophthalmol Scand 1996 Feb;74(1):81-3. doi: 10.1111/j.1600-0420.1996.tb00689.x. PMID: 8689490

Clinical prediction guides

Alsakran WA, Almadhi NH, Alshamrani AA, Alzahrani YA
Am J Case Rep 2020 Sep 8;21:e925926. doi: 10.12659/AJCR.925926. PMID: 32895362Free PMC Article
Herbort CP, Probst K, Cimino L, Tran VT
Klin Monbl Augenheilkd 2004 May;221(5):351-6. doi: 10.1055/s-2004-812827. PMID: 15162278
Sonoda S, Nakao K, Ohba N
Jpn J Ophthalmol 1999 Mar-Apr;43(2):113-9. doi: 10.1016/s0021-5155(98)00066-5. PMID: 10340793

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...